Annexin A5-functionalized nanoparticle for multimodal imaging of cell death

Molecular Imaging

Volumn 12, Issue 3, 2013, Pages

  Zhang, Rui ^a   Huang, Miao ^a   Zhou, Min ^a   Wen, Xiaoxia ^a   Huang, Qian ^a   Li, Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE MOLECULAR TOMOGRAPHY; FLUORESCENCE SIGNALS; FUNCTIONALIZED NANOPARTICLES; IMMUNOHISTOCHEMISTRY ASSAY; MULTI-MODAL IMAGING; NON-INVASIVE ASSESSMENTS; SINGLE-PHOTON EMISSION TOMOGRAPHY; THERAPEUTIC INTERVENTION;

ANTIBIOTICS; DIAGNOSIS; FLUORESCENCE; NONINVASIVE MEDICAL PROCEDURES; TISSUE; TOMOGRAPHY;

CELL DEATH;

CYCLOPHOSPHAMIDE; INDIUM; LIPOCORTIN 5; NANOPARTICLE;

ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DIAGNOSTIC IMAGING; FEMALE; GLIOSARCOMA; HUMAN; MOUSE; PROCEDURES; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECTROFLUOROMETRY;

ANIMALS; ANNEXIN A5; CYCLOPHOSPHAMIDE; DIAGNOSTIC IMAGING; FEMALE; GLIOSARCOMA; HUMANS; INDIUM RADIOISOTOPES; MICE; MICE, INBRED BALB C; NANOPARTICLES; SPECTROMETRY, FLUORESCENCE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84879223713     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2012.00032     Document Type: Article

References (36)

1. Hotchkiss RS, Strasser A, McDunn JE, et al. Cell death. N Engl Med J 2009;361:1570-83, doi:10.1056/NEJMra0901217.
2. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-9, doi:10.1056/NEJM199610173351603.
3. Tepper CG, Studzinski GP. Resistance of mitochondrial-DNA to degradation characterizes the apoptotic but not the necrotic mode of human leukemia-cell death. J Cell Biochem 1993;52:352-61, doi:10.1002/jcb.240520311.
4. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62, doi:10.1126/science.7878464.
5. Fadok VA, Savill JS, Haslett C, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992;149:4029-35.
6. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995;182:1597-601, doi:10.1084/jem.182.5.1597.
7. Koopman G, Reutelingsperger CPM, Kuijten GAM, et al. Annexin-V for flow cytometric detection of phosphatidylserine expression on B-cells undergoing apoptosis. Blood 1994;84:1415-20.
8. Tait JF, Smith C, Wood BL. Measurement of phosphatidylserine exposure in leukocytes and platelets by whole-blood flow cytometry with annexin V. Blood Cells Mol Dis 1999;25:271-8, doi:10.1006/bcmd.1999.0254.
9. Bennett MR, Gibson DF, Schwartz SM, et al. Binding and phagocytosis of apoptotic vascular smooth-muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 1995;77:1136-42, doi:10.1161/01.RES.77.6.1136.
10. ZhangGH, GurtuV,Kain SR, et al. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 1997;23:525-31.
11. Schellenberger EA, Weissleder R, Josephson L. Optimal modification of annexin V with fluorescent dyes. ChemBioChem 2004;5: 271-4, doi:10.1002/cbic. 200300741.
12. Wunder A, Schellenberger E, Mahmood U, et al. Methotrexateinduced accumulation of fluorescent annexin V in collageninduced arthritis. Mol Imaging 2005;4:1-6.
13. Glaser M, Collingridge DR, Aboagye EO, et al. Iodine-124 labelled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography. Appl Radiat Isot 2003;58:55-62, doi:10.1016/S0969-8043(02)00239-7.
14. Zijlstra S, Gunawan J, Burchert W. Synthesis and evaluation of a F-18-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl Radiat Isot 2003;58:201-7, doi:10.1016/S0969-8043(02)00302-0.
15. Blankenberg FG, Naumovski L, Tait JF, et al. Imaging cyclophosphamide- induced intramedullary apoptosis in rats using 99mTcradiolabeled annexin V. J Nucl Med 2001;42:309-16.
16. Murakami Y, Takamatsu H, Tait J, et al. F-18-labelled annexin V: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging 2004;31: 469-74.
17. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A 1998;95:6349-54, doi:10.1073/pnas.95.11.6349.
18. Blankenberg FG, Katsikis PD, Tait JF, et al. Imaging of apoptosis (programmed cell death) with Tc-99m annexin V. J Nucl Med 1999;40:184-91.
19. Blankenberg FG. In vivo detection of apoptosis. J Nucl Med 2008; 49:81s-95s, doi:10.2967/jnumed.107.045898.
20. Blankenberg FG, Tait JF, Blankenberg TA, et al. Imaging macrophages and the apoptosis of granulocytes in a rodent model of subacute and chronic abscesses with radiolabeled monocyte chemotactic peptide-1 and annexin V. Eur J Nucl Med 2001;28: 1384-93, doi:10.1007/s002590100572.
21. Gabrielson KL, Mok GS, Nimmagadda S, et al. Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomography. Mol Imaging 2008;7:132-8.
22. Schellenberger EA, Bogdanov A Jr, Ho?gemann D, et al. Annexin VCLIO: a nanoparticle for detecting apoptosis by MRI. Mol Imaging 2002;1:102-107.
23. van Tilborg GAF, Mulder WJM, Chin PTK, et al. Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjug Chem 2006; 17:865-8, doi:10.1021/bc0600463.
24. van Tilborg GA, Vucic E, Strijkers GJ, et al. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques. Bioconjug Chem 2010;21:1794-803, doi:10.1021/bc100091q.
25. Hiller KH, Waller C, Nahrendorf M, et al. Assessment of cardiovascular apoptosis in the isolated rat heart by magnetic resonance molecular imaging. Mol Imaging 2006;5:115-21.
26. Green DR, Beere HM. Apoptosis - gone but not forgotten. Nature 2000;405:28-9, doi:10.1038/35011175.
27. Zhang R, Lu W, Wen X, et al. Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis. J Nucl Med 2011;52:958-64, doi:10.2967/jnumed.110.083220.
28. Nguyen QD, Smith G, Glaser M, et al. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [F-18]-labeled isatin sulfonamide. Proc Natl Acad Sci U S A 2009;106:16375-80, doi:10.1073/pnas.0901310106.
29. Petrovsky A, Schellenberger E, Josephson L, et al. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res 2003;63:1936-42.
30. Emadi A, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 2009;6:638-47, doi:10.1038/nrclinonc.2009.146.
31. Ogasawara J, Watanabe-Fukunaga R, Tateno M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-9.
32. Kuge Y, Sato M, Zhao S, et al. Feasibility of 99mTc-annexin V for repetitive detection of apoptotic tumor response to chemotherapy: an experimental study using a rat tumor model. J Nucl Med 2004; 45:309-12.
33. Lin SH, Vincent A, Shaw T, et al. Prevention of nitric oxideinduced neuronal injury through the modulation of independent pathways of programmed cell death. J Cereb Blood Flow Metab 2000;20:1380-91, doi:10.1097/00004647- 200009000-00013.
34. Hammill AK, Uhr JW, Scheuermann RH. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res 1999;251:16-21, doi:10.1006/excr.1999.4581.
35. Gotthardt M, Bleeker-Rovers CP, Boerman OC, et al. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med 2010;51:1937-49, doi:10.2967/jnumed.110.076232.
36. Tokita N, Hasegawa S, Maruyama K, et al. Tc-99m-HYNICannexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis. Eur J Nucl Med Mol Imaging 2003; 30:232-8, doi:10.1007/s00259-002-1006-z.